Worse response axSpA patients to second TNFi versus first TNFi Presented ByDr Santiago Rodrigues-Manica, Hospital Egas Moniz, Portugal ConferenceEULAR 2020 14 August, 2020 10:27
AxSpA real-life remission rates higher on biologics Presented ByDr Charlotte Baert, Saint Luc University Hospital, Belgium ConferenceEULAR 2020 14 August, 2020 10:24
IL-6 and C-reactive protein as potential biomarkers for checkpoint inhibition Presented ByDr Jeffrey S. Weber, Laura and Isaac Perlmutter Cancer Centre, USA TrialCheckMate-064, CheckMate-066, CheckMate-067 ConferenceASCO 2019 15 July, 2019 23:55
Selective oral sphingosine 1-phosphate receptor modulator amiselimod ConferenceECCO 2019 9 May, 2019 22:21
Proactive adalimumab trough measurements Presented ByDr Amit Assa, Schneider Children’s Hospital, Israel ConferenceECCO 2019 9 May, 2019 10:20